Evidence map›Paper›PMID 22272352›Full record

ArticlePloS one2012

RhoE is regulated by cyclic AMP and promotes fusion of human BeWo choriocarcinoma cells.

Gavin P Collett, Xue Fang Goh, Elizabeth A Linton, Christopher W G Redman, Ian L Sargent

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Biophysical Considerations in Cell Fusion.Advances in experimental medicine and biology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Maternal RND3/RhoE deficiency impairs placental mitochondrial function in preeclampsia by modulating the PPARγ-UCP2 cascade.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Pathophysiological Functions of Rnd3/RhoE.Comprehensive Physiology · 2015
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gavin P CollettNuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom. Gavin.Collett@obs-gyn.ox.ac.uk
Xue Fang Goh
Elizabeth A Linton
Christopher W G Redman
Ian L Sargent
University of Oxford · GB

Funding

Medical Research Council MR/J003360/1Wellcome TrustWellcome Trust GR079862MA
6 · The paper itself

Abstract

Fusion of placental villous cytotrophoblasts with the overlying syncytiotrophoblast is essential for the maintenance of successful pregnancy, and disturbances in this process have been implicated in pathological conditions such as pre-eclampsia and intra-uterine growth retardation. In this study we examined the role of the Rho GTPase family member RhoE in trophoblast differentiation and fusion using the BeWo choriocarcinoma cell line, a model of villous cytotrophoblast fusion. Treatment of BeWo cells with the cell permeable cyclic AMP analogue dibutyryl cyclic AMP (dbcAMP) resulted in a strong upregulation of RhoE at 24 h, coinciding with the onset of fusion. Using the protein kinase A (PKA)-specific cAMP analogue N(6)-phenyl-cAMP, and a specific inhibitor of PKA (14-22 amide, PKI), we found that upregulation of RhoE by cAMP was mediated through activation of PKA signalling. Silencing of RhoE expression by RNA interference resulted in a significant decrease in dbcAMP-induced fusion. However, expression of differentiation markers human chorionic gonadotrophin and placental alkaline phosphatase was unaffected by RhoE silencing. Finally, we found that RhoE upregulation by dbcAMP was significantly reduced under hypoxic conditions in which cell fusion is impaired. These results show that induction of RhoE by cAMP is mediated through PKA and promotes BeWo cell fusion but has no effect on functional differentiation, supporting evidence that these two processes may be controlled by separate or diverging pathways.

Indexed as

Alkaline PhosphataseBucladesineCarrier ProteinsCell DifferentiationCell FusionCell HypoxiaCell Line, TumorCells, CulturedChoriocarcinomaChorionic GonadotropinCyclic AMP-Dependent Protein KinasesEnzyme ActivationEnzyme InhibitorsFemaleGPI-Linked ProteinsHumansAlkaline Phosphatasealkaline phosphatase, placentalBucladesineCarrier ProteinsChorionic GonadotropinCyclic AMP-Dependent Protein KinasesEnzyme InhibitorsGPI-Linked ProteinsIsoenzymesmyristoylated protein kinase A inhibitor amide 14-22Peptide Fragmentsrho GTP-Binding ProteinsRND3 protein, human

Identifiers

PMID22272352
PMCPMC3260294
OpenAlexW2020823922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.